a single-blind , randomized trial was carried out in 30 out-patients with osteoarthritis to compare the efficacy and tolerability of the new osmotic-release formulation , 'osmosin ' ( 7 mg indomethacin per hour over a period of approximately 10 hours ) , with that of piroxicam .
C0029408
osteoarthritis
C0031990
piroxicam